December 13, 2023
Life-changing Therapeutics
The U.S. Food and Drug Administration recently approved the first available therapeutic treatment for a rare, life-threatening genetic disorder. TAK-755, commercially known as Adzynma, was developed over the past two decades in the laboratory of U-M researcher David Ginsburg. This marks the seventh U-M invention that has secured FDA approval